The 2nd JCG Meeting (January 28, 2004)1 The 2 nd Japan CDISC Group (JCG) Meeting 28 January 2004 Yoshio Tsukada JCG Leader.

Slides:



Advertisements
Similar presentations
Educational Activities 2013 Karen Panetta R1 Educational Activities August 24,2013.
Advertisements

Education Work stream Update English Speaking User Network F2F Meeting 15 th of December 2008 Veronica Martin.
A-16 Portfolio Management Implementation Plan Update
HT Pharmaceuticals Clinical Research Consulting Humphrey Tebit, Principal.
Dr. M. Iwasaki 1 Asian Multinational Clinical Trials - Current Status & Future Direction - Dr.Masaru IWASAKI PR Japan Operations Center Aventis Pharma,
What’s New with CDISC Wayne R. Kubick CDISC CTO.
CSCMP ROUNDTABLES One CSCMP.
A Report on Japan’s International Cooperation for Bridging the Global Digital Divide What is becoming of the $15 billion equivalent pledged during the.
CDASH Initiative Rhonda Facile Project Director, CDISC CDASH Project Update Atlantic User Group 21 February 2008.
1 Who We Are. What We Do EphMRA/PBIRG Classification Committee.
2 nd International ASIA QA FORUM EVENT INFO This event will be a venue for all QA specialists and scientists working in Asia to expand their intellectual.
Tipologie di Audit e loro caratteristiche Riunione sottogruppo GCP-GIQAR 21 Marzo 2006 Francesca Bucchi.
ROTARY INTERNATIONAL’S STRATEGIC PLAN. WHAT IS A STRATEGIC PLAN? It is a living management tool that: Provides long-term direction Builds a shared vision.
Bay Area CDISC Implmentation Network – July 13, 2009 How a New CDISC Domain is Made Carey Smoak Team Leader CDISC SDTM Device Team.
July 2002PMI-SOC FY031 FY03 Business Plan VP Projects Joanne Gumaer July 2002.
Clinical Trials Market in Russia 17 October 2008 ROTOBO - ACTO.
Industry Perspective on Challenges for Product Developers - Drugs Christine Allison, M.S., RAC Associate Regulatory Consultant, Global Regulatory Affairs.
Gateway To Technology Wauwatosa School District. Provide our middle school students access to Science, Technology, Engineering, Math (STEM) programming.
QBASE Engineering © QBASE Engineering Sdn Bhd Measurement System Analysis – MSA Course Description Total Quality Management ( TQM) is being pursued by.
Company Coordinator Example By Chuck Wray - Sipchem WORKING GREEN.
Presentation by Lia van Ginneken – EMP Secretary & João Salazar – EMP Chairman 21st February 2009.
Training Opportunities What is New Upcoming Events Member Update Our Member spotlight is Karsten Gamble, an Indianapolis Device Manufacturing Engineer.
Second Annual Japan CDISC Group (JCG) Meeting 28 January 2004 Julie Evans Director, Technical Services.
PhUSE Computational Science Working Groups Solutions Through Collaboration.
CDISC South African User Group (SAUG) 28-Mar-2012 Co-leaders: Dianne Weatherall, Marielle Knott Presenters: Loryn Thorburn Laurent Marais Wouter van Wyk.
Welcome to Course A3-2387: Trade Union Training on OSHE ILO/ACTRAV-Turin Orientation and Objectives.
CRIX: toward a secure, standards-based, clinical research information exchange.
Tony, Yen-Huei Tarn, M.S., Ph.D. President, TaSPOR Introduction of Taiwan Society for Pharmacoeconomics and Outcomes Research (TaSPOR) ISPOR 2ND ASIA-PACIFIC.
The 2nd JCG Meeting (January 28, 2004)1 The 2 nd Japan CDISC Group (JCG) Meeting Nobuaki.Sakashita Education & Membership Task Force.
Dr. Mike Ferris Clinical Data for JNDA based on Bridging Japanese Data PK/PD data Bridging trial Foreign Data PK/PD data Trial to compare with bridging.
Regulated Product Submission HL7 Update Wednesday January 10 th, 2007 Jason Rock
1 SDS&ADaM sub-team 28 January 2004 Mineko FUJIMOTO Rieko ICHIHARA Kazue TOMITA Hiroaki MATSUDA.
Comprehensive Marketing Plan Presentation February 22, 2012 Indiana University Kelley MBA Students Lauren Feldman Medha Hazari Chris Mahon Jen Michuda.
HANC and Community Partners Overview November 20, 2007 Michael Petillo, Project Coordinator.
The 2nd JCG Meeting (January 28, 2004)1 Public Relations (PR) and Communications Task Force Kiyoteru Takenouchi, Ph.D. Dendrite Japan Corporation Clinical.
CDISC Update December 2007 / January 2008 Pierre-Yves Lastic, PhD CDISC Board of Directors & E3C February 5, Paris.
1 Records Management Organization The Committee provides guidance on operating the company’s records management program.
CAPACITY DEVELOPMENT FOR CDM IN VIET NAM Presented by Nguyen Mong Cuong Project CD4CDM - Viet Nam Outline  Overview of project  Project activities and.
Part 11 Public Meeting PEERS Questions & Responses The opinions expressed here belong to PEERS members and not the corporate entities with which they are.
CDISC User Group in Deutschland/Japan Hajime Shimizu (nickname: Akiba) CDISC Japan User Group introduction to team activity.
Hajar Sabuur Johnson & Johnson Worldwide Information Security June 16, 2005
FDA Standards Development and Implementation Randy Levin, M.D. Director, Office of Information Management Center for Drug Evaluation and Research Food.
CDISC – 17/12/2012 Carine Javierre Nathalie SABIN.
Geneva Branch INTRODUCTION TO CDISC Biometristi Italiani Associati – Seminario BIAS CDISC SDTM and ADaM: Moving from theory to practice SAS Institute –
Ericsson Response © 2000 Think and Act both Think and Act both Locally and Globally Åsa Aronson and Jesper Mott.
Swissmedic Swiss Agency for Therapeutic Products Hallerstrasse 7 CH-3000 Bern From Step 2 to Step 3 of the eCTD Introduction 2nd Follow-up.
Developing a Space Weather Capability in your Region – Training to Utilize the WMO Space Weather Product Portal Terry Onsager Physicist – U.S. National.
Medical Writing Special Interest Area Community (SIAC) Medical Communications March Workshop 2012 David Clemow SIAC Chair Melissa Ossanna Communications.
DIA Medical Writing SIAC All-SIAC Teleconference 06 January :00-12:00 am EST DIAL: US: Int: (44) Pass Code: #
Presented by Jenny Griffiths Data Standards Office, PD Biometrics,
Global Clinical Trials Market Share, Global Trends, Analysis, Research, Report, Opportunities, Segmentation and Forecast,
Regulated Product Submission Eileen M. Girten, MS i3 Statprobe 1DIA Education SIAC.
Paper Destruction Team Full Team Meeting 9 April 2013.
Dave Iberson-Hurst CDISC VP Technical Strategy
Placebo / Standard of Care (PSoC)
Presented by Jenny Griffiths Data Standards Office, PD Biometrics,
E-Rare and IRDiRC: Future collaboration perspectives?
Field Investigation Drug Officer Workshop Goals and Objectives
Minimum wages implementation in informal sectors:
The 2nd JCG Meeting (January 28, 2004)
28 January 2004 Mineko FUJIMOTO Motohide NISHI Masahiro YOKOKAWA
Second Annual Japan CDISC Group (JCG) Meeting
MGT 498 EDU Perfect Education/ mgt498edu.com.
Freundschaft Konferenz
PhUSE Computational Science
Introduction to TransCelerate
District Leadership Plan
A two-phase, faculty and staff driven process
North Asia Regional Aviation
1st German CDISC User Group Meeting
Presentation transcript:

The 2nd JCG Meeting (January 28, 2004)1 The 2 nd Japan CDISC Group (JCG) Meeting 28 January 2004 Yoshio Tsukada JCG Leader

The 2nd JCG Meeting (January 28, 2004)2 Overview of JCG CDISC History in Japan CDISC History in Japan JCG Membership & Structure JCG Membership & Structure Expectations on CDISC in Japan Expectations on CDISC in Japan Current and Future Activity Current and Future Activity

The 2nd JCG Meeting (January 28, 2004)3 CDISC History in Japan Jan 2002First introduction in Japan Jan 2002First introduction in Japan May 2002CDISC Japan Meeting May 2002CDISC Japan Meeting Nov 2002J3C formed Nov 2002J3C formed Jan 2003JCG Kick-off Meeting Jan 2003JCG Kick-off Meeting Apr st JCG Meeting Apr st JCG Meeting May 2003Activities started May 2003Activities started Jan nd JCG Meeting Jan nd JCG Meeting

The 2nd JCG Meeting (January 28, 2004)4 JCG Membership & Structure Membership Two types of JCG Membership Contribute as a Corporate Sponsor/member Company Contribute as a Corporate Sponsor/member Company Contribute as an Individual Volunteer Contribute as an Individual Volunteer Devotes his/her time to CDISC activities in Japan for the time being, and recommend to be a Corporate sponsor/member in the near future

The 2nd JCG Meeting (January 28, 2004)5 Membership

The 2nd JCG Meeting (January 28, 2004)6 65 Individuals from 40 Companies Individual Company As of January 1, 2004

The 2nd JCG Meeting (January 28, 2004)7 Structure of JCG European CDISC Group

The 2nd JCG Meeting (January 28, 2004)8 J3C Japan CDISC Coordinating Committee Mineko Fujimoto (Schering) Rieko Ichihara (Pfizer) Hiroaki Matsuda (Boehringer-Ingelheim) Motohide Nishi (Yamanouchi) Nobuaki Sakashita (Parexel) Kiyoteru Takenouchi (Dendrite) Kazue Tomita (Eli Lilly) Masahiro Yokokawa (Parexel) Yoshio Tsukada (Aventis)

The 2nd JCG Meeting (January 28, 2004)9 Size of TF and Modeling Teams in JCG 46 (including team leader)

The 2nd JCG Meeting (January 28, 2004)10 Expectations on CDISC in Japan Facilitate ‘business’ processes among Investigators, Pharmaceutical companies, CROs, Clinical Laboratories, Technology vendors Facilitate ‘business’ processes among Investigators, Pharmaceutical companies, CROs, Clinical Laboratories, Technology vendors Increase efficiencies of performing clinical trials Increase efficiencies of performing clinical trials Facilitate reviews of regulatory submissions Facilitate reviews of regulatory submissions Provide means for long-term archive of electronic clinical trial data and digital signatures Provide means for long-term archive of electronic clinical trial data and digital signatures Support to utilize Foreign clinical data in Japan Support to utilize Foreign clinical data in Japan Support to provide Japanese clinical data to US/EU Support to provide Japanese clinical data to US/EU Fix the foundations for Multi-national/regional clinical trials including Japan Fix the foundations for Multi-national/regional clinical trials including Japan

The 2nd JCG Meeting (January 28, 2004)11 Support and facilitate CDISC implementation in Japan Support and facilitate CDISC implementation in Japan Contribute to the establishment of CDISC Standards included Japanese local requirements Contribute to the establishment of CDISC Standards included Japanese local requirements JCG Mission

The 2nd JCG Meeting (January 28, 2004)12 Current Activity (till 2003) Introduction and Learning CDISC in Japan Education & Membership Education & Membership PR/Communications PR/Communications Modeling Teams Modeling Teams  ODM (Operational Data Model)  LAB (Laboratory Data Model)  SDS (Submission Data Standards)  ADaM (Analysis Data Model) JCG Update

The 2nd JCG Meeting (January 28, 2004)13 Future Activity (2004 onward) Support and facilitate CDISC Implementation in Japan Increase Awareness Increase Awareness Share information in JCG Share information in JCG Organize Training Courses Organize Training Courses Influence Regulatory Authority Influence Regulatory Authority Facilitate CDISC Standards into daily business Facilitate CDISC Standards into daily business

The 2nd JCG Meeting (January 28, 2004)14 JCG: Past and Future Introduction phase Learning phase Implementation phase

The 2nd JCG Meeting (January 28, 2004)15 Nobuaki Sakashita (Education & Membership) Kiyoteru Takenouchi (PR/Coms) Mineko Fujimoto (Modeling) Yoshio Tsukada JCG Contacts

The 2nd JCG Meeting (January 28, 2004)16 Think Globally Act Locally Thank you! Japan CDISC Group